Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04486781
Title A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vasgene Therapeutics, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.